Lenz therapeutics, inc.LENZ.US Overview

US StockHealthcare

(No presentation for LENZ)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

LENZ Overall Performance

LENZ AI Analysis & Strategy

LENZ Recent Performance

1.16%

Lenz therapeutics, inc.

0.81%

Avg of Sector

-1.14%

S&P500

LENZ PowerScanner

LENZ Key Information

LENZ Valuation Metrics

LENZ Earnings Table

LENZ Profile

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.